News - Financial

Filter

Current filters:

Financial

Popular Filters

46 to 70 of 1452 results

US Court upholds damages award in Actelion/Asahi litigation

14-03-2014

Switzerland-based Actelion says that the California Supreme Court has denied the firm’ petition for…

ActelionAsahi KaseiBiotechnologyfasudilFinancialLegalNorth AmericaRespiratory and PulmonaryUSA

Pharma Summit: AIDS activists picket to demand South African reform

Pharma Summit: AIDS activists picket to demand South African reform

14-03-2014

Delegates at The Economist’s Pharma Summit in London yesterday were greeted by AIDS activists picketing…

Anti-viralsFinancialLegalPharmaceuticalPricingSouth AfricaUK

Vectura to buy Germany’s Activaero for 130 million euros

Vectura to buy Germany’s Activaero for 130 million euros

14-03-2014

UK developer of inhaled therapies Vectura says it is acquiring privately-held German company Activaero…

ActivaeroFinancialMergers & AcquisitionsPharmaceuticalRespiratory and PulmonaryVectura

Novo Nordisk invests $100 million in new purification pilot plant in Denmark

Novo Nordisk invests $100 million in new purification pilot plant in Denmark

14-03-2014

Danish insulin giant Novo Nordisk revealed this morning that it is increasing its drug development capacity…

DiabetesFinancialNovo NordiskPharmaceuticalProduction

Generic drugs slow pharma spending growth in Canada

Generic drugs slow pharma spending growth in Canada

13-03-2014

Last year, C$29.3 billion ($26.47 billion) was spent on prescription drugs in Canada, but the annual…

CanadaFinancialGenericsMarkets & MarketingNorth AmericaPharmaceutical

Bayer foresees 8% pa sales growth for pharma through 2016

Bayer foresees 8% pa sales growth for pharma through 2016

13-03-2014

Germany’s Bayer expects strong growth for its pharmaceutical business as a result of a number of new…

AdempasBayerEyleaFinancialPharmaceuticalStivargaXareltoXofigo

Hikma delivers group revenue growth of 23% and EPS up 111% for 2013

Hikma delivers group revenue growth of 23% and EPS up 111% for 2013

12-03-2014

Jordon-headquartered Hikma Pharmaceuticals today reported its preliminary results for the year ended…

FinancialGenericsHikma Pharmaceuticals

Teva agrees $27.6 million settlement with US Justice Dept

Teva agrees $27.6 million settlement with US Justice Dept

12-03-2014

US subsidiaries of Israeli generics giant Teva Pharmaceutical Industries have agreed to pay the US government…

ClozapineFinancialGenericsIvaxLegalNeurologicalNorth AmericaTeva Pharmaceutical IndustriesUSA

New wave of technology drives breakthrough approaches in Life Sciences commercial operations, says IMS

12-03-2014

Life sciences companies are aggressively embracing new technology-driven approaches to commercialize…

FinancialManagementPharmaceutical

Bayer to invest 500 million-euro-plus in hemophilia products manufacturing in Germany

Bayer to invest 500 million-euro-plus in hemophilia products manufacturing in Germany

12-03-2014

German pharma major Bayer revealed yesterday that it plans an investment of more than 500 million euros…

BayerFinancialGermanyHematologyNorthern EuropePharmaceuticalProduction

Marina Biotech to use its therapeutics platform to develop drugs for rare diseases

11-03-2014

US RNAi-based drug discover Marina Biotech says that it plans to broadly apply its RNAi, antisense and…

BiotechnologyFinancialMarina BiotechRare diseasesResearch

France Biotech pledges to increase partnering with big pharma in 2014 plan

France Biotech pledges to increase partnering with big pharma in 2014 plan

11-03-2014

Trade body France Biotech has outlined its priorities for 2014 with a focus on innovation and removing…

BiotechnologyFinancialFrancePolitics

Biotie invests in Alzheimer’s drug SYN120 as it drops epilepsy pathway

Biotie invests in Alzheimer’s drug SYN120 as it drops epilepsy pathway

11-03-2014

Finland-based Biotie Therapies (Nasdaq OMX: BTH1V), which is focused on neurodegenerative and psychiatric…

BiotechnologyBiotie TherapiesFinancialFinlandHealthcareNeurologicalNRL-1SYN120

FDA accepts Lundbeck NDA for IV carbamazepine

FDA accepts Lundbeck NDA for IV carbamazepine

10-03-2014

The US subsidiary of Danish CNS specialist Lundbeck says that the Food and Drug Administration has accepted…

CarbamazepineCarbellaFinancialLigand PharmaceuticalsLundbeckNeurologicalNorth AmericaPharmaceuticalRegulationUSA

Asia-Pacific region sees boom in Biotech investment

Asia-Pacific region sees boom in Biotech investment

07-03-2014

The Asia-Pacific (APAC) region is experiencing a significant boom in the volume of private equity (PE)…

Asia-PacificBiotechnologyFinancialPatents

Report: R&D market is diversifying innovation, with increased partnerships, mergers and revenue sharing models

06-03-2014

The R&D sector is set to grow at more than 8% driven by new evaluation techniques, according to CPhI…

FinancialGlobalPharmaceuticalResearch

Pharming income drops in 2013 but expects sales to grow this year

06-03-2014

Dutch biotech firm Pharming Group saw its shares rise 8.7% to 0.60 euros after publishing its preliminary…

BiotechnologyFinancialNetherlandsPharmingRuconest

Report: US drug companies cut payments to doctors by up to 62%

06-03-2014

Some of the USA’s largest pharmaceutical companies have cut payments to health professionals for promotional…

FinancialLegalPharmaceuticalUSA

Roche and Novartis fined for cartelizing sales of eye drugs Avastin and Lucentis in Italy

Roche and Novartis fined for cartelizing sales of eye drugs Avastin and Lucentis in Italy

06-03-2014

Swiss pharma majors Roche and Novartis colluded to exclude the cheaper cancer drug Avastin (bevacizumab),…

AvastinEuropeFinancialItalyLegalLucentisNovartisOphthalmicsPharmaceuticalRoche

Germany’s Merck benefits from efficiency measures, with 2013 EBITDA up 9.7%

Germany’s Merck benefits from efficiency measures, with 2013 EBITDA up 9.7%

06-03-2014

German pharma and chemical major Merck KGaA this morning announced strong fourth-quarter and full-year…

FinancialMerck KGaAMerck SeronoPharmaceutical

Hawaii Biotech awarded $5.5million government grant for botulism therapy

Hawaii Biotech awarded $5.5million government grant for botulism therapy

05-03-2014

Privately-held US biotech company Hawaii Biotech has been awarded a contract to continue developing drugs…

BiotechnologyFinancialHawaii BiotechRare diseasesResearchUSA

Cell Therapeutics sees 2013 revenue rise thanks to Baxter deal

05-03-2014

US biotech firm Cell Therapeutics (Nasdaq: CTIC) revenue soared last year to $34.7 million, due to a…

BiotechnologyCell TherapeuticsFinancialpacritinibUSA

Spanish pharma companies return to sales growth in 2013, after dismal 2012

Spanish pharma companies return to sales growth in 2013, after dismal 2012

04-03-2014

Spanish pharmaceutical companies, reporting their 2013 financial results, have started to see light at…

AlmirallEuropeFaes FarmaFinancialGrifolsPharmaceuticalZeltia

AusBiotech continues its call for further tax reform in Australia

AusBiotech continues its call for further tax reform in Australia

04-03-2014

Building on the strategic plan that was presented at AusBiotech national conference last November by…

Asia-PacificAustraliaBiotechnologyFinancialResearch

46 to 70 of 1452 results

Back to top